Wilmer Cutler Pickering Hale and Dorr represented the underwriters.Kymera Therapeutics, Inc. (Nasdaq: KYMR) (Kymera), a clinical-stage biopharmaceutical company, announced its public offering of 2,830,533 shares of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
